How malaria parasites exploit mechanism for escaping elimination could provide novel strategies targeting chronic malaria ...

In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone service.

CEO Serge Saxonov, PhD, acknowledged that its R&D operation “definitely ended up being impacted in a substantial way” while ...

Researchers were able to test how viruses replicate differently across various bat species and organs using the new organoid ...

The American Society of Gene and Cell Therapy (ASGCT) meeting is off and running in New Orleans! Kevin Davies, PhD, editorial director and Julianna LeMieux, PhD, deputy editor in chief at GEN are on ...

Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of food-associated allergic and inflammatory diseases.

Estrogen-related receptors (ERRs) regulate muscle mitochondria in mice, revealing a new potential drug targets for metabolic diseases.

To address this challenge, CTMC has established a patient material bank, enabling early-stage process development with clinically relevant samples. This resource also supports continuous process ...

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows ...

TAHITI couples CRISPR with transposable elements from plants to edit cash crops such as corn and soybean with reduced ...

Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and ...

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.